0001209191-16-087904.txt : 20160104
0001209191-16-087904.hdr.sgml : 20160104
20160104171814
ACCESSION NUMBER: 0001209191-16-087904
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160101
FILED AS OF DATE: 20160104
DATE AS OF CHANGE: 20160104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptimmune Therapeutics PLC
CENTRAL INDEX KEY: 0001621227
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 101 PARK DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RY
BUSINESS PHONE: 44 1235 430000
MAIL ADDRESS:
STREET 1: 101 PARK DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RY
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptimmune Ltd
DATE OF NAME CHANGE: 20141001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Florence Anthony A. Jr.
CENTRAL INDEX KEY: 0001559827
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37368
FILM NUMBER: 161319167
MAIL ADDRESS:
STREET 1: 5425 WISCONSIN AVENUE, SUITE 800
CITY: CHEVY CHASE
STATE: MD
ZIP: 20815
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2016-01-01
0
0001621227
Adaptimmune Therapeutics PLC
ADAP
0001559827
Florence Anthony A. Jr.
5425 WISCONSIN AVENUE
SUITE 800
CHEVY CHASE
MD
20815
0
0
1
0
Ordinary Shares with a nominal value of 0.001 GBP per share
59269000
I
See Note 1
The Reporting Person is a director of NEA 14 GP, LTD, which is the sole general partner of NEA Partners 14, L.P. ("NEA Partners 14"). NEA Partners 14 is the sole general partner of New Enterprise Associates 14, L.P. ("NEA 14"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 shares in which the Reporting Person has no pecuniary interest.
/s/ Sasha Keough, attorney-in-fact
2016-01-04